A Brief History of Psychedelic Therapy

A Brief History of Psychedelic Therapy

Psychedelic therapy is a form of treatment that has been used for centuries to help people deal with various mental health issues. Psychedelic therapy involves the use of psychoactive substances, such as LSD, psilocybin, and ketamine, to achieve a therapeutic effect. In recent years, there has been a resurgence of interest in psychedelic therapy, particularly in the use of ketamine infusion therapy.

In this blog post, we will explore the history of psychedelic therapy, with a focus on ketamine infusion therapy.

Early Uses of Psychedelic Therapy

The use of psychoactive substances for therapeutic purposes dates back centuries. Ancient cultures, such as the Greeks and the Mayans, used hallucinogenic plants in their religious rituals to achieve altered states of consciousness. Similarly, traditional healers in various cultures used psychoactive plants to treat a range of conditions, from depression and anxiety to physical ailments.

In the 1950s and 1960s, researchers in the Western world became interested in the therapeutic potential of psychedelics. They began conducting clinical trials using substances such as LSD and psilocybin to treat various mental health conditions, including depression, anxiety, and addiction.

These early studies showed promising results, but the widespread use of psychedelics as therapeutic agents was cut short by the government’s crackdown on these substances in the 1970s.

The Resurgence of Psychedelic Therapy

In recent years, there has been a resurgence of interest in the therapeutic potential of psychedelics. This renewed interest can be attributed to several factors, including advances in neuroscience, the growing prevalence of mental health issues, and the increasing acceptance of alternative therapies.

One of the most promising psychedelics for therapeutic use is ketamine. Originally developed as an anesthetic, ketamine has been used off-label for the treatment of depression and other mental health conditions since the 1990s. In 2019, the US Food and Drug Administration (FDA) approved a nasal spray formulation of ketamine, called esketamine, for the treatment of treatment-resistant depression.

Ketamine Infusion Therapy

Ketamine infusion therapy is a form of psychedelic therapy that involves the administration of ketamine through an intravenous (IV) infusion. The treatment is usually administered in a clinical setting under the supervision of a medical professional.

Ketamine infusion therapy has been shown to be effective in the treatment of a range of mental health conditions, including depression, anxiety, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). The treatment works by modulating the activity of various neurotransmitters in the brain, including glutamate, GABA, and dopamine.

The History of Ketamine

Ketamine was first synthesized in the early 1960s by Calvin Stevens, a scientist working for the pharmaceutical company Parke-Davis. Originally developed as an anesthetic, ketamine quickly gained popularity due to its rapid onset of action, low cost, and relatively low risk of respiratory depression.

In the 1990s, researchers began exploring the use of ketamine for the treatment of depression. Early studies showed that low doses of ketamine could rapidly alleviate symptoms of depression in patients who were resistant to traditional antidepressant medications. These studies also showed that the effects of ketamine lasted for several days to several weeks, suggesting that the treatment had long-lasting effects.

In the years that followed, researchers continued to explore the therapeutic potential of ketamine. They found that ketamine was effective in the treatment of a range of mental health conditions, including anxiety, PTSD, and OCD.

The Future of Ketamine Infusion Therapy

The future of ketamine infusion therapy is promising, with ongoing research exploring its potential to treat a variety of mental health conditions. As more studies are conducted, we may gain a better understanding of the mechanisms underlying ketamine’s therapeutic effects, which could lead to the development of more targeted and effective treatments.

Additionally, advances in technology may make ketamine infusion therapy more accessible and convenient for patients. For example, researchers are currently exploring the use of ketamine nasal sprays and other non-invasive methods of administration. Overall, the future of ketamine infusion therapy is exciting, and it holds the potential to revolutionize the treatment of mental health conditions.

Final Thoughts

At Infuse RVA, we are proud to offer ketamine infusion therapy as a safe and effective treatment option for individuals struggling with depression, anxiety, PTSD, and other mental health conditions. As a clinic dedicated to the advancement of psychedelic therapies, we believe that ketamine infusion therapy represents a powerful tool in the fight against mental illness.

We are committed to staying at the forefront of research in this field and providing our patients with the most up-to-date and effective treatments available. If you or a loved one are struggling with a mental health condition, we encourage you to explore the benefits of ketamine infusion therapy and to contact us to learn more about our services. Let us help you take the first step toward a brighter future.

Share Now :


Designed to help bring out radiance and natural glow, this kit includes six treatments of premium-quality compounds believed to fortify hair, skin and nails, reduce wrinkles and quench skin from the inside out.

Possible Benefits

What's Inside

Ascorbic Acid

Ascorbic acid can act as an antioxidant that may help protect cells from free-radical damage, absorb iron, create collagen and boost immunity.

B-Complex Vitamins

B-complex vitamins may help keep skin and blood cells healthy as well as convert nutrients into energy.


Biotin is one of the B vitamins (a.k.a. Vitamin B7), which can fortify keratin infrastructure and may help promote healthy hair, skin, and nails.